Piezo1’s pleiotropic roles in cancer reflect tissue-specific mechanotransduction programs: pro-fibrotic/pro-tumorigenic in liver diseases, yet tumor-suppressive in NSCLC and gastric cancer. Here, PIEZO1 is linked to neoplasm.